What research topics does IMI fund?
The research funded under IMI aims to address the IMI Research Agenda, which was compiled through stakeholder consultation and is available on the IMI website. The research funded is aimed at addressing problems in the medicines development process:
- Predicting safety: this addresses bottlenecks related to accurately evaluating the safety of a compound during the pre-clinical phase of the development process, but also impacts the later phases in clinical development.
- Predicting efficacy: this addresses bottlenecks in the ability to predict how a drug will interact in humans and how it may produce a change in function.
- Knowledge management: this addresses the more effective utilisation of information and data for predicting safety and efficacy.
- Education and training: this closes existing training gaps in the drug development process.
Information about the calls, including the guide for applicants and rules for participation is available on the IMI website.
For further information about the call or the application process please contact the UK National Contact Point for the Health Theme:
Victoria Brewer
victoria.brewer@headoffice.mrc.ac.uk